- Home
- PYXS vs INO Comparison
PYXS vs INO Comparison
Compare PYXS & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- INO
- Stock Information
- Founded
- PYXS 2018
- INO 1979
- Country
- PYXS United States
- INO United States
- Employees
- PYXS N/A
- INO N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- PYXS Health Care
- INO Health Care
- Exchange
- PYXS Nasdaq
- INO Nasdaq
- Market Cap
- PYXS 75.0M
- INO 69.3M
- IPO Year
- PYXS 2021
- INO 1998
- Fundamental
- Price
- PYXS $1.10
- INO $1.43
- Analyst Decision
- PYXS Strong Buy
- INO Buy
- Analyst Count
- PYXS 5
- INO 5
- Target Price
- PYXS $9.00
- INO $8.80
- AVG Volume (30 Days)
- PYXS 387.8K
- INO 2.3M
- Earning Date
- PYXS 08-13-2025
- INO 08-15-2025
- Dividend Yield
- PYXS N/A
- INO N/A
- EPS Growth
- PYXS N/A
- INO N/A
- EPS
- PYXS N/A
- INO N/A
- Revenue
- PYXS N/A
- INO $283,099.00
- Revenue This Year
- PYXS N/A
- INO N/A
- Revenue Next Year
- PYXS N/A
- INO $20,588.06
- P/E Ratio
- PYXS N/A
- INO N/A
- Revenue Growth
- PYXS N/A
- INO N/A
- 52 Week Low
- PYXS $0.83
- INO $1.30
- 52 Week High
- PYXS $5.39
- INO $10.67
- Technical
- Relative Strength Index (RSI)
- PYXS 43.52
- INO 40.77
- Support Level
- PYXS $1.12
- INO $1.41
- Resistance Level
- PYXS $1.38
- INO $1.56
- Average True Range (ATR)
- PYXS 0.08
- INO 0.08
- MACD
- PYXS -0.01
- INO 0.02
- Stochastic Oscillator
- PYXS 5.08
- INO 43.33
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.